Kamagra Oral Jelly, which contains sildenafil citrate, is primarily used to treat erectile dysfunction (ED). While sildenafil is also used in higher doses to treat pulmonary hypertension, Kamagra Oral Jelly is not typically recommended for this purpose. Sildenafil for Pulmonary Hypertension: Medication: Sildenafil, in the form of Revatio, is approved for the treatment of pulmonary arterial hypertension (PAH). The dosage and formulation used for PAH are different from those used for ED. Dosage: For pulmonary hypertension, sildenafil is usually prescribed in higher doses than those used for treating ED. The typical dose for PAH is 20 mg three times a day, whereas Kamagra Oral Jelly is usually prescribed in 50 mg doses for ED. Formulation: Kamagra Oral Jelly is formulated for ED and is not intended for use in treating PAH. The concentration and form of sildenafil in Kamagra Oral Jelly are tailored for ***** function, not for pulmonary conditions. Important Considerations: Medical Supervision: Using sildenafil for PAH requires careful medical supervision and a specific dosage that may not be available in Kamagra Oral Jelly. Safety: Using ED medications for conditions other than their intended use can be risky. It’s important to use medications as prescribed by a healthcare provider and to follow their guidance on appropriate treatments. If you or someone else needs treatment for pulmonary hypertension, consult a healthcare provider to get a prescription for the appropriate medication and dosage specifically approved for that condition.